RL

Rajappavu Lily Sunjay Pradhep

Active Director Director DIN 11134119
DIN 11134119 First appointment Jun 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajappavu Lily Sunjay Pradhep

Data last updated:

Rajappavu Lily Sunjay Pradhep is a Director at Kani Healthcare Private Limited (since 2025). The company operates in Healthcare.

DIN 11134119
Primary Designation Director
Industry Healthcare
First Appointment 02 Jun 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kani Healthcare Private Limited U86100TN2025PTC181053
Director02 Jun 20252025Active

Board colleagues of Rajappavu Lily Sunjay Pradhep

NameDINCompanyDesignation
Ambrose Rajappavu11134118Kani Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Kani Healthcare Private Limited
Premium access

Shareholding and investment profile for Rajappavu Lily Sunjay Pradhep

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajappavu Lily Sunjay Pradhep

Rajappavu Lily Sunjay Pradhep currently holds 1 directorship: Kani Healthcare Private Limited (Director, since 02 Jun 2025).

Rajappavu Lily Sunjay Pradhep was first appointed on 02 Jun 2025 as Director at Kani Healthcare Private Limited.

The current boards of Rajappavu Lily Sunjay Pradhep's companies include Ambrose Rajappavu (Kani Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available